Linked here is a detailed quantitative analysis of Abbott Laboratories (ABT). Below are some highlights from the above linked analysis: Company Description: This diversified health care products company is now focused on nutritionals, diagnostics, generic drugs, and medical devices, following the spinoff of its R&D-based prescription pharmaceuticals business at the beginning of 2013.
ABT did not earn any Stars in the Fair Value section, earned two Stars in the Dividend Analytical Data section and did not earn any Stars in the Dividend Income vs. MMA section for a total of two Stars. This quantitatively ranks ABT as a...
Source: Dividend Growth Stocks
Related Articles:
Dividend Growth Stocks News
- Seeking Up to 11% Dividend Yield? Analysts Pick 2 Dividend Stocks to Buy - TipRanks - 8/17/2025
- 3 Asian Dividend Stocks Yielding Up To 9.4% - Yahoo Finance - 8/14/2025
- 3 Dividend Stocks to Hold for the Next 5 Years - The Motley Fool - 8/17/2025
- 3 “Strong Buy” Dividend Stocks with Over 20% Upside, According to Analysts, 8/17/2025 - TipRanks - 8/17/2025
- 7.7% and 8.7% yields! 2 dividend stocks I’m considering buying to hold until 2035 - uk.finance.yahoo.com - 8/17/2025
- Archer Daniels Midland Company (ADM) Dividend Stock Analysis - 8/15/2025
- Nucor Corporation (NUE) Dividend Stock Analysis - 8/8/2025
- Raytheon Technologies Corporation (RTX) Dividend Stock Analysis - 7/31/2025
- Duke Energy (DUK) Dividend Stock Analysis - 7/25/2025
- Chevron Corporation (CVX) Dividend Stock Analysis - 7/18/2025
Abbott Laboratories (ABT) Dividend Stock Analysis
Posted by D4L | Monday, May 01, 2023 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.